☰

Dara L. Burdette - Publications

Affiliations: 
2009-2013 University of California, Berkeley, Berkeley, CA, United States 
Tree Info Similar researchers PubMed Report error

14/24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Holm CK, Rahbek SH, Gad HH, Bak RO, Jakobsen MR, Jiang Z, Hansen AL, Jensen SK, Sun C, Thomsen MK, Laustsen A, Nielsen CG, Severinsen K, Xiong Y, Burdette DL, et al. Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses. Nature Communications. 7: 10680. PMID 26893169 DOI: 10.1038/Ncomms10680  0.345
2015 Sreelatha A, Bennett TL, Carpinone EM, O'Brien KM, Jordan KD, Burdette DL, Orth K, Starai VJ. Vibrio effector protein VopQ inhibits fusion of V-ATPase-containing membranes. Proceedings of the National Academy of Sciences of the United States of America. 112: 100-5. PMID 25453092 DOI: 10.1073/Pnas.1413764111  0.678
2013 Diner EJ, Burdette DL, Wilson SC, Monroe KM, Kellenberger CA, Hyodo M, Hayakawa Y, Hammond MC, Vance RE. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Reports. 3: 1355-61. PMID 23707065 DOI: 10.1016/J.Celrep.2013.05.009  0.62
2013 Barker JR, Koestler BJ, Carpenter VK, Burdette DL, Waters CM, Vance RE, Valdivia RH. STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection. Mbio. 4: e00018-13. PMID 23631912 DOI: 10.1128/Mbio.00018-13  0.683
2013 Conlon J, Burdette DL, Sharma S, Bhat N, Thompson M, Jiang Z, Rathinam VA, Monks B, Jin T, Xiao TS, Vogel SN, Vance RE, Fitzgerald KA. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. Journal of Immunology (Baltimore, Md. : 1950). 190: 5216-25. PMID 23585680 DOI: 10.4049/Jimmunol.1300097  0.665
2013 Burdette DL, Vance RE. STING and the innate immune response to nucleic acids in the cytosol. Nature Immunology. 14: 19-26. PMID 23238760 DOI: 10.1038/Ni.2491  0.648
2013 Leong M, Kanne D, Glickman L, Lemmens E, Lauer P, Metchette K, Burdette D, Diner E, Fu J, Soares K, Brockstedt D, Portnoy D, Vance R, Kim Y, Jaffee E, et al. Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines Journal For Immunotherapy of Cancer. 1: O20. DOI: 10.1186/2051-1426-1-S1-O20  0.716
2011 Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, Hayakawa Y, Vance RE. STING is a direct innate immune sensor of cyclic di-GMP. Nature. 478: 515-8. PMID 21947006 DOI: 10.1038/Nature10429  0.76
2009 Burdette DL, Seemann J, Orth K. Vibrio VopQ induces PI3-kinase-independent autophagy and antagonizes phagocytosis. Molecular Microbiology. 73: 639-49. PMID 19627496 DOI: 10.1111/J.1365-2958.2009.06798.X  0.571
2009 Burdette DL, Yarbrough ML, Orth K. Not without cause: Vibrio parahaemolyticus induces acute autophagy and cell death. Autophagy. 5: 100-2. PMID 19011375 DOI: 10.4161/Auto.5.1.7264  0.541
2008 Burdette DL, Yarbrough ML, Orvedahl A, Gilpin CJ, Orth K. Vibrio parahaemolyticus orchestrates a multifaceted host cell infection by induction of autophagy, cell rounding, and then cell lysis. Proceedings of the National Academy of Sciences of the United States of America. 105: 12497-502. PMID 18713860 DOI: 10.1073/Pnas.0802773105  0.562
2008 Hao YH, Wang Y, Burdette D, Mukherjee S, Keitany G, Goldsmith E, Orth K. Structural requirements for Yersinia YopJ inhibition of MAP kinase pathways. Plos One. 3: e1375. PMID 18167536 DOI: 10.1371/Journal.Pone.0001375  0.569
2007 Liverman ADB, Cheng HC, Trosky JE, Leung DW, Yarbrough ML, Burdette DL, Rosen MK, Orth K. Arp2/3-independent assembly of actin by Vibrio type III effector VopL Proceedings of the National Academy of Sciences of the United States of America. 104: 17117-17122. PMID 17942696 DOI: 10.1073/Pnas.0703196104  0.546
2004 Trosky JE, Mukherjee S, Burdette DL, Roberts M, McCarter L, Siegel RM, Orth K. Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus. The Journal of Biological Chemistry. 279: 51953-7. PMID 15459200 DOI: 10.1074/Jbc.M407001200  0.613
Low-probability matches (unlikely to be authored by this person)
2006 Rothberg KG, Burdette DL, Pfannstiel J, Jetton N, Singh R, Ruben L. The RACK1 homologue from Trypanosoma brucei is required for the onset and progression of cytokinesis. The Journal of Biological Chemistry. 281: 9781-90. PMID 16469736 DOI: 10.1074/Jbc.M600133200  0.254
2017 Niu C, Livingston CM, Li L, Beran RK, Daffis S, Ramakrishnan D, Burdette D, Peiser L, Salas E, Ramos H, Yu M, Cheng G, Strubin M, Delaney Iv WE, Fletcher SP. The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection. Plos One. 12: e0169648. PMID 28095508 DOI: 10.1371/journal.pone.0169648  0.22
2021 Liu Y, Chang S, Hsieh D, Burdette D, Martin R, Mo H, Feierbach B. Generation of an HBV Core Phenotyping Assay for Evaluating HBV Capsid Compounds. Journal of Virological Methods. 114117. PMID 33657432 DOI: 10.1016/j.jviromet.2021.114117  0.167
2022 Burdette D, Hyrina A, Song Z, Beran RK, Cheung T, Gilmore S, Kobayashi T, Li L, Liu Y, Niedziela-Majka A, Medley J, Mehra U, Morganelli P, Novikov N, Niu C, et al. Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection. Antimicrobial Agents and Chemotherapy. e0134822. PMID 36519892 DOI: 10.1128/aac.01348-22  0.162
2020 Hong X, Luckenbaugh L, Mendenhall M, Walsh R, Cabuang L, Soppe S, Revill P, Burdette D, Feierbach B, Delaney W, Hu J. Characterization of Hepatitis B Precore/Core-Related Antigens. Journal of Virology. PMID 33148795 DOI: 10.1128/JVI.01695-20  0.161
2022 Hyrina A, Burdette D, Song Z, Ramirez R, Okesli-Armlovich A, Vijayakumar A, Bates J, Trevaskis JL, Fletcher SP, Lee WA, Holdorf MM. Targeting lipid biosynthesis pathways for hepatitis B virus cure. Plos One. 17: e0270273. PMID 35925919 DOI: 10.1371/journal.pone.0270273  0.158
2019 Wang S, Fogeron ML, Schledorn M, Dujardin M, Penzel S, Burdette D, Berke JM, Nassal M, Lecoq L, Meier BH, Böckmann A. Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation. Frontiers in Molecular Biosciences. 6: 67. PMID 31440516 DOI: 10.3389/fmolb.2019.00067  0.152
2022 Burdette DL, Lazerwith S, Yang J, Chan HLY, Delaney Iv WE, Fletcher SP, Cihlar T, Feierbach B. Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy. Plos One. 17: e0262516. PMID 35363817 DOI: 10.1371/journal.pone.0262516  0.128
2023 Lecoq L, Brigandat L, Huber R, Fogeron ML, Wang S, Dujardin M, Briday M, Wiegand T, Callon M, Malär A, Durantel D, Burdette D, Berke JM, Meier BH, Nassal M, et al. Molecular elucidation of drug-induced abnormal assemblies of the hepatitis B virus capsid protein by solid-state NMR. Nature Communications. 14: 471. PMID 36709212 DOI: 10.1038/s41467-023-36219-3  0.126
2019 Burdette D, Cathcart A, Shauf A, Win R, Zaboli S, Hedskog C, Svarovskaia ES, Barry V, Inzunza D, Flaherty JF, Gaggar A, Fletcher S, Chan H, Mo H, Lazerwith S, et al. PS-150-Evidence for the presence of infectious virus in the serum from chronic hepatitis B patients suppressed on nucleos (t)ide therapy with detectable but not quantifiable HBV DNA Journal of Hepatology. 70: e95. DOI: 10.1016/S0618-8278(19)30168-9  0.106
Hide low-probability matches.